Aurinia Pharmaceuticals financials at a glance

+ Portfolio

The revenue of Aurinia Pharmaceuticals is reported as 0.17551 billion Dollars in the fiscal year 2023. The earnings were -0.54 Dollars per share in 2023, which was 28.95 higher than 2022. And about -0.03418 billion Dollars are reported as free cash flow in the financials of Aurinia Pharmaceuticals 2023. No dividends were paid to the shareholders of the Aurinia Pharmaceuticals stock NasdaqGM:AUPH in the financial year 2023.

$175.51M

Revenue

$-0.54

Earnings Per Share

87.65%

Gross Margin %

$-86.00M

Free Cash Flow

Revenue

175.51

Earnings Per Share

-0.54

Gross Margin %

87.65

Free Cash Flow

-86.00

Financials

Year	Year	TTM	2023	2022	2021	2020	2019	2018	2017	2016	2015
Rev.	Revenue	N/A	$175.51M	$134.03M	$45.60M	$50.12M	$0.32M	$0.46M	$0.42M	$0.17M	$0.24M
GM %	Gross Margin %	63.96%	87.65%	62.21%	-14.53%	-0.42%	0.00%	0.00%	0.00%	0.00%	0.00%
OM	Operating Margin	-56.73%	-48.88%	-83.17%	0.00%	-,208.09%	0.00%	0.00%	0.00%	0.00%	0.00%
EPS	Earnings Per Share	$-0.54	$-0.54	$-0.76	$-1.40	$-0.87	$-0.89	$-0.64	$-0.61	$-0.66	$-0.74
Div.	Dividends	N/A	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
PR %	Payout Ratio %	0	0	0	0	0	0	0	0	0	0
Sha.	Shares	N/AM	144.62M	142.58M	141.65M	127.45M	112.3M	91.64M	84.05M	52.81M	32.29M
OCF	Operating Cash Flow	N/A	$-33.46M	$-79.53M	$-,157.69M	$-69.86M	$-63.46M	$-51.61M	$-41.17M	$-18.71M	$-17.77M
FCF	Free Cash Flow	N/A	$-86.00M	$-79.82M	$-,157.99M	$-75.44M	$-63.54M	$-51.64M	$-41.19M	$-18.73M	$-17.78M
FCFS	Free Cash Flow Per Share	$-0.27	$-0.24	$-0.56	$-1.28	$-0.65	$-0.68	$-0.61	$-0.54	$-0.53	$-0.55

Aurinia Pharmaceuticals financials at a glance

Financials

Discover